Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral ...
For more information, submit a form at ICON plc Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at [email protected], or call us at (212) 951-2030. According ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback